Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,168
  • Shares Outstanding, K 2,637
  • Annual Sales, $ 1,410 K
  • Annual Income, $ -7,370 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 3.27
  • Price/Sales 4.15
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.76
  • Number of Estimates 2
  • High Estimate $-0.53
  • Low Estimate $-0.99
  • Prior Year $-6.24
  • Growth Rate Est. (year over year) +87.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2900 +37.60%
on 03/24/26
2.4600 -27.85%
on 03/17/26
-0.4750 (-21.11%)
since 03/16/26
3-Month
1.2900 +37.60%
on 03/24/26
8.6200 -79.41%
on 01/22/26
-0.6650 (-27.25%)
since 01/16/26
52-Week
1.2900 +37.60%
on 03/24/26
17.6800 -89.96%
on 04/22/25
-10.9050 (-86.00%)
since 04/16/25

Most Recent Stories

More News
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website

Travelers can now purchase the only once-weekly, broad-spectrum malaria preventive online, through the Runway Health telehealth platform WASHINGTON, April 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees...

SXTP : 1.7200 (-12.24%)
SXTPW : 0.0914 (unch)
Infrastructure Capital and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies will air interviews with Infrastructure Capital Advisors, LLC (NYSE:SCAP)(NYSE:PFFA)(NYSE:BNDS) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP)...

BNDS : 51.12 (-0.03%)
PFFA : 21.67 (+0.05%)
SXTP : 1.7200 (-12.24%)
SCAP : 36.92 (-0.06%)
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming virtual...

NXL : 0.4630 (-9.04%)
BIVI : 1.4550 (+3.19%)
SXTP : 1.7200 (-12.24%)
BFRG : 1.0300 (+9.85%)
LTRN : 2.72 (+12.40%)
60 Degrees Pharmaceuticals Announces 2025 Annual Results

FY 2025 net product revenues increased 65% to $1,005,000 Current shelf capacity exhausted after raise of $4 million through an ATM facility WASHINGTON, March 31, 2026 (GLOBE NEWSWIRE) -- 60 Degrees...

SXTP : 1.7200 (-12.24%)
SXTPW : 0.0914 (unch)
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract

FDA has until May 25, 2026 to object to the notification, after which the Company will be free to market its proposed dietary supplement containing Australian Chestnut Extract Company has signed an option...

SXTP : 1.7200 (-12.24%)
SXTPW : 0.0914 (unch)
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial

All three patients enrolled in study have been cured, confirming high cure rate of  tafenoquine in immunosuppressed patients, as reported by Yale in a 2024 publication Company calls for existing babesiosis...

SXTP : 1.7200 (-12.24%)
SXTPW : 0.0914 (unch)
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks,...

BIVI : 1.4550 (+3.19%)
SXTP : 1.7200 (-12.24%)
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership

GoodRx to offer prescription savings of up to 30% for ARAKODA ® ( tafenoquine ) Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company’s marketing strategy Partnership...

GDRX : 2.36 (+1.72%)
SXTP : 1.7200 (-12.24%)
SXTPW : 0.0914 (unch)
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use

WASHINGTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc.  (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing...

SXTP : 1.7200 (-12.24%)
SXTPW : 0.0914 (unch)
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention

Partnership adds a travel-focused consumer telehealth platform to the ARAKODA ® marketing strategy, offering a new convenience to people planning travel to malaria-endemic regions of the world ARAKODA...

SXTP : 1.7200 (-12.24%)
SXTPW : 0.0914 (unch)

Business Summary

60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.

See More

Key Turning Points

3rd Resistance Point 2.8267
2nd Resistance Point 2.6133
1st Resistance Point 2.2867
Last Price 1.7200
1st Support Level 1.7467
2nd Support Level 1.5333
3rd Support Level 1.2067

See More

52-Week High 17.6800
Fibonacci 61.8% 11.4190
Fibonacci 50% 9.4850
Fibonacci 38.2% 7.5510
Last Price 1.7200
52-Week Low 1.2900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.